Jnj price target.

Johnson & Johnson Declares $1.19 Quarterly Dividend; 3.1% Yield. Johnson & Johnson (JNJ) declared a quarterly dividend of $1.19 per share, or $4.76 annualized. The dividend will be payable on December 5, 2023, to stockholders of record on November 21,... Investing.com.

Jnj price target. Things To Know About Jnj price target.

Stelara's total sales were $2,864 million in Q3 2023, an increase of 16.9% year-over-year. The company's management raised its financial guidance for full-year 2023 adjusted-diluted EPS from $10 ...JNJ's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend.com: The #1 Source For Dividend Investing. ... 15% price target upside from sell-side analysts. Top 40%. Quant Recommendation - JNJ. Maximize Income Goal. ... SEll JNJ shares when price recovers. Sell Date (Estimate) Feb 29, 2024. Avg Price …Find real-time JNJ - Johnson & Johnson stock quotes, company profile, news and forecasts from CNN Business. ... Price/Book: 5.19: Competitors Today’s change Today’s % change; NONOF Novo ... Let’s discover JPMorgan stock price predictions. The average 12-month price target of 21 Wall Street analysts is $150.61. A potential maximum price is placed at $200.00; simultaneously, the price can fall to $80.00. The consensus rating is "Buy", as 14 analysts set it, 5 analysts recommend holding stocks, and only 2 experts advise to sell …Let’s discover JPMorgan stock price predictions. The average 12-month price target of 21 Wall Street analysts is $150.61. A potential maximum price is placed at $200.00; simultaneously, the price can fall to $80.00. The consensus rating is "Buy", as 14 analysts set it, 5 analysts recommend holding stocks, and only 2 experts advise to sell …

Johnson & Johnson (JNJ) reports a strong first quarter, with sales up more than 5.5% and earnings eking out an annual increase. ... trimming our price target to $195 per share in an acknowledgment ...Wall Street analysts forecast JNJ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for JNJ is 179.57 USD with a low forecast of 156.55 USD and a high forecast of 225.75 USD .The 19 analysts offering 12-month price forecasts for Johnson & Johnson have a median target of 172.00, with a high estimate of 215.00 and a low estimate of 155.00.

Pepsi’s traditional target market is teenagers and young adults, according to Forbes magazine. In that vein, its taglines over the years have included “Live for Now” and the “Pepsi Generation.”

The latest price target for . Johnson & Johnson (NYSE: JNJ) was reported by Cantor Fitzgerald on November 20, 2023.The analyst firm set a price target for $215.00 expecting JNJ to rise to within ... According to investigation by KrebsOnSecurity, Home Depot has been a victim of the same type of security threat that affected Target, with credit card numbers stolen and put up for sale online. Time to check your statements. According to in...The 34 Wall Street analysts offering JOHNSON & JOHNSON stock forecast in the last 6 months have average price target of $188.03 with a high forecast of $215.0 and a low forecast of $40.0. The average JOHNSON & JOHNSON stock forecast represents a 18.72% increase from the last price of $158.380004882812.Oct 18, 2023 · Johnson & Johnson price target raised to $165 from $162 at Barclays 10/18/23 Wells Fargo Johnson & Johnson price target lowered to $178 from $186 at Wells Fargo.

JNJ US4781601046 Market Closed - Nyse. Other stock markets. 04:00:02 2023-12-01 pm EST 5-day change 1st Jan Change 158.38 USD ... Wells Fargo Cuts Price Target on Johnson & Johnson to $178 From $186, Keeps Overweight Rating Oct. 18. MT ...

Target values for the price of one Johnson & Johnson share for Nov 2025. The weighted average target price per Johnson & Johnson share in Nov 2025 is: 169.36. In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 2.892% volatility is expected. Pessimistic target level: 167.89.

Jul 25, 2023 · The new price target of $175 reflects Barclays' belief that Johnson & Johnson (NYSE:JNJ) shares have the potential to reach that level in the future, signaling their confidence in the company's ... An analyst from Raymond James maintained J&J (NYSE: JNJ) at 'outperform' with a price target of $172.00 from a prior price target of $179.00. Prior to this rating, J&J had 9 buy... Investing.com. Oct 18, 2023 11:16.Stelara's total sales were $2,864 million in Q3 2023, an increase of 16.9% year-over-year. The company's management raised its financial guidance for full-year 2023 adjusted-diluted EPS from $10 ...An analyst from Stifel maintained J&J (NYSE: JNJ) at 'hold' with a price target of $155.00 from a prior price target of $170.00. Prior to this rating, J&J had 9 buy ratings, 13... Investing.com; Nov 10, 2023 11:48; Johnson & Johnson's MedTech to seek FDA approval for Ottava in 2024 .Jun 17, 2022 · The stock has a Moderate Buy consensus rating based on six Buys, three Holds, and zero Sell ratings.The average Johnson & Johnson price target is $194.89, implying 14.5% upside potential ...

Mar 29, 2023 · As of March 28, 2023, the average one-year price target for Johnson & Johnson is $184.52. The forecasts range from a low of $162.61 to a high of $225.75. The average price target represents an ... Get today's JNJ stock price and latest Johnson & Johnson stock news as well as JNJ real-time stock quotes, technical analysis, full financials and more. ... Analysts 12-Month Price Target. 175.09 ...JNJ stock has seen little change, moving slightly from levels of $155 in ... forecast includes probability-adjusted revenue for these drugs. If any issues ...Johnson & Johnson (JNJ) reports a strong first quarter, with sales up more than 5.5% and earnings eking out an annual increase. ... trimming our price target to $195 per share in an acknowledgment ...Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9% ...Johnson & Johnson analyst ratings, historical stock prices, earnings estimates & actuals. JNJ updated stock price target summary.

All site users must consult qualified professional advisors before making any trades. We get stock prices and financial data from our 3rd party supplier, EODHistorical data, while we acquire analysts’ ratings and price targets from publicly available sources such as financial websites, newsfeeds and published reports.

Target values for the price of one Johnson & Johnson share for Oct 2026. The weighted average target price per Johnson & Johnson share in Oct 2026 is: 174.81. In Oct, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 3.748% volatility is expected. Pessimistic target level: 171.28.JNJ US4781601046 Market Closed - Nyse. Other stock markets. 04:00:02 2023-12-01 pm EST 5-day change 1st Jan Change 158.38 USD ... Wells Fargo Cuts Price Target on Johnson & Johnson to $178 From $186, Keeps Overweight Rating Oct. 18. MT ...Johnson & Johnson (JNJ) Stock Price & News - Google Finance Markets Home JNJ • NYSE Johnson & Johnson Follow Share $158.38 After Hours: $158.30 (0.051%) -0.080 …Advertisement Determining the right target audience is probably the most important part of your marketing efforts, because it doesn't matter what you're saying if you're not saying it to the right people. In this section of your marketing p...Nov 29, 2023 · Price Target. Based on short-term price targets offered by 17 analysts, the average price target for Johnson & Johnson comes to $177.88. The forecasts range from a low of $155.00 to a... The average price target for JNJ is $168.00, which is 11.05% higher than the current price. The consensus rating is "Buy". Price Target : $168.00: Price Target Difference : 11.05%: Analyst Consensus : Buy: Analyst Count : 15: Revenue Growth Forecast (5Y) 0.13%: EPS Growth Forecast (5Y) 12.24%:An analyst from Stifel maintained J&J (NYSE: JNJ) at 'hold' with a price target of $155.00 from a prior price target of $170.00. Prior to this rating, J&J had 9 buy ratings, 13... Investing.com; Nov 10, 2023 11:48; Johnson & Johnson's MedTech to seek FDA approval for Ottava in 2024 .The latest price target for . Johnson & Johnson (NYSE: JNJ) was reported by Cantor Fitzgerald on November 20, 2023.The analyst firm set a price target for $215.00 expecting JNJ to rise to within ...

UBS has upgraded the stock from Neutral to Buy with a price target of $180, up from $167, primarily driven by a more meaningful upside vs. consensus for the next few years. ... Price Action: JNJ ...

Oct 31, 2023 · Stelara's total sales were $2,864 million in Q3 2023, an increase of 16.9% year-over-year. The company's management raised its financial guidance for full-year 2023 adjusted-diluted EPS from $10 ...

The above table shows the analyst JNJ forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$154.66In its current portfolio, Capital Research & Management Co holds 27,825,795 shares valued at $4.5 billion. In terms of Johnson & Johnson share price expectations, FactSet research, analysts set an average price target of $180.26 in the next 12 months, up nearly 15.87% from the previous closing price of $155.34.Oct 18, 2023 · Johnson & Johnson price target raised to $165 from $162 at Barclays 10/18/23 Wells Fargo Johnson & Johnson price target lowered to $178 from $186 at Wells Fargo. According to the issued ratings of 29 analysts in the last year, the consensus rating for Target stock is Hold based on the current 16 hold ratings and 13 buy ratings for TGT. The average twelve-month price prediction for Target is $154.39 with a high price target of $200.00 and a low price target of $116.00.The average price target for Johnson & Johnson is $178.02. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $215.00 ,the lowest forecast is $165.00. The average price target represents 20.76% Increase from the current price of $147.42.An analyst from Stifel maintained J&J (NYSE: JNJ) at 'hold' with a price target of $155.00 from a prior price target of $170.00. Prior to this rating, J&J had 9 buy ratings, 13... Investing.com; Nov 10, 2023 11:48; Johnson & Johnson's MedTech to seek FDA approval for Ottava in 2024 .Analyst Price Forecast Suggests 16.11% Upside As of November 27, 2023, the average one-year price target for Johnson & Johnson is 179.57. The forecasts range from a low of 156.55 to a high of $225.75.1Y Price Target. $173.28. Price Target Upside 10.48% Upside. Rating Consensus Moderate Buy. Number of Analyst Covering 18. Show more. JPMorgan Chase & Co. News. All News. TipRanks News. Press Releases. The Fly Keefe says Apple ending Goldman partnership not big surprise. 3d ago.In a report released on September 1, Rick Wise from Stifel Nicolaus maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), with a price target of $170.00. The company’s shares ...Nov 29, 2023 · Price Target. Based on short-term price targets offered by 17 analysts, the average price target for Johnson & Johnson comes to $177.88. The forecasts range from a low of $155.00 to a... Analyst Price Forecast Suggests 16.56% Upside As of August 31, 2023, the average one-year price target for Johnson & Johnson is 187.29. The forecasts range from a low of 168.67 to a high of $225.75.Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9% ...

After an 11.22% decline in its share price over the past year, the average JNJ price target of $176.38 per share implies 14.16% upside potential. Disclosure. More for You.1y Target Est 174.48 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate.Dec 6, 2022 · Dec. 6, 2022, 10:25 AM. Morgan Stanley analyst Terence Flynn maintained a Hold rating on Johnson & Johnson ( JNJ - Research Report) today and set a price target of $176.00. The companys shares ... JNJ Price Target. For more insight on analysts targets of JNJ, see our JNJ price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page. Average Price Target: $187.95: Average Broker Recommendation: 1.53 (Moderate Buy)Instagram:https://instagram. where to buy hess trucksrsv vaccine manufacturerssolarcity sharestrading futures vs options The price target of a stock is the price at which the stock is fairly valued with respect to its historical and projected earnings. Investors can maximize their rates of return by buying and selling stocks when they are trading below and ab... farmers small business insurancebest international mutual fund Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing. ... 1y Target Est: 174.48: Fair Value is the ... best ev stocks for long term Price target. 175.42 0.00 0.00%. The 19 analysts offering 1 year price forecasts for JNJ have a max estimate of — and a min estimate of —. Analyst rating. Based on 23 analysts giving stock ratings to JNJ in the past 3 months. …The Johnson & Johnson (JNJ) stock price forecast for the next 12 months is generally negative, with an average analyst price target of $140.70, representing a -11.16% increase from the current price of $158.38. The highest analyst price target is $152.71, and the lowest is $128.69.231.40. -1.20%. 108.31K. Find the latest Johnson & Johnson (JNJ) stock forecast, 12-month price target, predictions and analyst recommendations.